Why Wall Street “Missed the Bus” on Rigel Pharmaceuticals
Sometimes, it’s the little things that can weigh you down. Take Rigel Pharmaceuticals (RIGL) for example. We recommended this clinical-stage biotechnology company last month, and it has not performed as we expected.
Read More